IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v15y2024i1d10.1038_s41467-024-45132-2.html
   My bibliography  Save this article

The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer

Author

Listed:
  • Chandra Sekhar Amara

    (Baylor College of Medicine)

  • Karthik Reddy Kami Reddy

    (Baylor College of Medicine
    Baylor College of Medicine)

  • Yang Yuntao

    (University of Texas Health Science Center at Houston)

  • Yuen San Chan

    (Baylor College of Medicine
    Baylor College of Medicine
    Baylor College of Medicine)

  • Danthasinghe Waduge Badrajee Piyarathna

    (Baylor College of Medicine)

  • Lacey Elizabeth Dobrolecki

    (Baylor College of Medicine
    Baylor College of Medicine)

  • David J. H. Shih

    (University of Texas Health Science Center at Houston)

  • Zhongcheng Shi

    (Baylor College of Medicine)

  • Jun Xu

    (Baylor College of Medicine
    Baylor College of Medicine)

  • Shixia Huang

    (Baylor College of Medicine
    Baylor College of Medicine
    Baylor College of Medicine
    Innovation and Technology, Baylor College of Medicine)

  • Matthew J. Ellis

    (Baylor College of Medicine)

  • Andrea B. Apolo

    (Center for Cancer Research, National Cancer Institute, National Institutes of Health)

  • Leomar Y. Ballester

    (The University of Texas MD Anderson Cancer Center)

  • Jianjun Gao

    (The University of Texas MD Anderson Cancer Center)

  • Donna E. Hansel

    (The University of Texas MD Anderson Cancer Center)

  • Yair Lotan

    (University of Texas Southwestern Medical Center)

  • H. Courtney Hodges

    (Baylor College of Medicine
    Baylor College of Medicine
    Baylor College of Medicine
    Rice University)

  • Seth P. Lerner

    (Baylor College of Medicine)

  • Chad J. Creighton

    (Baylor College of Medicine
    Baylor College of Medicine)

  • Arun Sreekumar

    (Baylor College of Medicine
    Baylor College of Medicine)

  • W. Jim Zheng

    (University of Texas Health Science Center at Houston)

  • Pavlos Msaouel

    (Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center
    The University of Texas, MD Anderson Cancer Center)

  • Shyam M. Kavuri

    (Baylor College of Medicine)

  • Nagireddy Putluri

    (Baylor College of Medicine
    Baylor College of Medicine
    Baylor College of Medicine)

Abstract

SMARCB1 loss has long been observed in many solid tumors. However, there is a need to elucidate targetable pathways driving growth and metastasis in SMARCB1-deficient tumors. Here, we demonstrate that SMARCB1 deficiency, defined as genomic SMARCB1 copy number loss associated with reduced mRNA, drives disease progression in patients with bladder cancer by engaging STAT3. SMARCB1 loss increases the chromatin accessibility of the STAT3 locus in vitro. Orthotopically implanted SMARCB1 knockout (KO) cell lines exhibit increased tumor growth and metastasis. SMARCB1-deficient tumors show an increased IL6/JAK/STAT3 signaling axis in in vivo models and patients. Furthermore, a pSTAT3 selective inhibitor, TTI-101, reduces tumor growth in SMARCB1 KO orthotopic cell line-derived xenografts and a SMARCB1-deficient patient derived xenograft model. We have identified a gene signature generated from SMARCB1 KO tumors that predicts SMARCB1 deficiency in patients. Overall, these findings support the clinical evaluation of STAT3 inhibitors for the treatment of SMARCB1-deficient bladder cancer.

Suggested Citation

  • Chandra Sekhar Amara & Karthik Reddy Kami Reddy & Yang Yuntao & Yuen San Chan & Danthasinghe Waduge Badrajee Piyarathna & Lacey Elizabeth Dobrolecki & David J. H. Shih & Zhongcheng Shi & Jun Xu & Shix, 2024. "The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer," Nature Communications, Nature, vol. 15(1), pages 1-16, December.
    • Handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-45132-2
    DOI: 10.1038/s41467-024-45132-2
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-024-45132-2
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-024-45132-2?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-45132-2. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.